207 related articles for article (PubMed ID: 17185354)
21. All trans-retinoic acid induces apoptosis via p38 and caspase pathways in metaplastic Barrett's cells.
Hormi-Carver K; Feagins LA; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2007 Jan; 292(1):G18-27. PubMed ID: 16935849
[TBL] [Abstract][Full Text] [Related]
22. Tissue culture of epithelium derived from Barrett's oesophagus.
Washington K; Gottfried MR; Telen MJ
Gut; 1994 Jul; 35(7):879-83. PubMed ID: 8063213
[TBL] [Abstract][Full Text] [Related]
23. Cellular origin of Barrett's metaplasia and oesophageal stem cells.
Barbera M; Fitzgerald RC
Biochem Soc Trans; 2010 Apr; 38(2):370-3. PubMed ID: 20298185
[TBL] [Abstract][Full Text] [Related]
24. Review article: Barrett's oesophagus, dysplasia and pharmacologic acid suppression.
Fitzgerald RC; Lascar R; Triadafilopoulos G
Aliment Pharmacol Ther; 2001 Mar; 15(3):269-76. PubMed ID: 11207503
[TBL] [Abstract][Full Text] [Related]
25. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
26. Long-term proton pump induced hypergastrinaemia does induce lineage-specific restitution but not clonal expansion in benign Barrett's oesophagus in vivo.
Obszynska JA; Atherfold PA; Nanji M; Glancy D; Santander S; Graham TA; Otto WR; West K; Harrison RF; Jankowski JA
Gut; 2010 Feb; 59(2):156-63. PubMed ID: 19651631
[TBL] [Abstract][Full Text] [Related]
27. Endoscopic regression of Barrett's oesophagus during omeprazole treatment; a randomised double blind study.
Peters FT; Ganesh S; Kuipers EJ; Sluiter WJ; Klinkenberg-Knol EC; Lamers CB; Kleibeuker JH
Gut; 1999 Oct; 45(4):489-94. PubMed ID: 10486353
[TBL] [Abstract][Full Text] [Related]
28. K-ras point mutations are rare events in premalignant forms of Barrett's oesophagus.
Trautmann B; Wittekind C; Strobel D; Meixner H; Keymling J; Gossner L; Ell C; Hahn EG
Eur J Gastroenterol Hepatol; 1996 Aug; 8(8):799-804. PubMed ID: 8864678
[TBL] [Abstract][Full Text] [Related]
29. The role of acid and bile reflux in oesophagitis and Barrett's metaplasia.
Souza RF
Biochem Soc Trans; 2010 Apr; 38(2):348-52. PubMed ID: 20298181
[TBL] [Abstract][Full Text] [Related]
30. Gastric-type mucin and TFF-peptide expression in Barrett's oesophagus is disturbed during increased expression of MUC2.
Van De Bovenkamp JH; Korteland-Van Male AM; Warson C; Büller HA; Einerhand AW; Ectors NL; Dekker J
Histopathology; 2003 Jun; 42(6):555-65. PubMed ID: 12786891
[TBL] [Abstract][Full Text] [Related]
31. Barrett's oesophagus with predominant intestinal metaplasia correlates with superficial cyclo-oxygenase-2 expression, increased proliferation and reduced apoptosis: changes that are partially reversed by non-steroidal anti-inflammatory drugs usage.
Amano Y; Ishihara S; Kushiyama Y; Yuki T; Takahashi Y; Chinuki D; Miyake T; Miyaoka Y; Rumi MA; Ishimura N; Adachi K; Kinoshita Y
Aliment Pharmacol Ther; 2004 Oct; 20(7):793-802. PubMed ID: 15379840
[TBL] [Abstract][Full Text] [Related]
32. The expression of 8-hydroxydeoxyguanosine in oesophageal tissues and tumours.
Räsänen JV; Sihvo EI; Ahotupa MO; Färkkilä MA; Salo JA
Eur J Surg Oncol; 2007 Dec; 33(10):1164-8. PubMed ID: 17467227
[TBL] [Abstract][Full Text] [Related]
33. Impact of gastro-oesophageal reflux on microRNA expression, location and function.
Smith CM; Michael MZ; Watson DI; Tan G; Astill DS; Hummel R; Hussey DJ
BMC Gastroenterol; 2013 Jan; 13():4. PubMed ID: 23297865
[TBL] [Abstract][Full Text] [Related]
34. Experimental columnar metaplasia in the canine oesophagus.
Gillen P; Keeling P; Byrne PJ; West AB; Hennessy TP
Br J Surg; 1988 Feb; 75(2):113-5. PubMed ID: 3349294
[TBL] [Abstract][Full Text] [Related]
35. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
36. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
37. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.
Sharma P; Weston AP; Topalovski M; Cherian R; Bhattacharyya A; Sampliner RE
Gut; 2003 Jan; 52(1):24-7. PubMed ID: 12477754
[TBL] [Abstract][Full Text] [Related]
38. Assessment of proliferation of squamous, Barrett's and gastric mucosa in patients with columnar lined Barrett's oesophagus.
Iftikhar SY; Steele RJ; Watson S; James PD; Dilks K; Hardcastle JD
Gut; 1992 Jun; 33(6):733-7. PubMed ID: 1624150
[TBL] [Abstract][Full Text] [Related]
39. GATA6 expression in Barrett's oesophagus and oesophageal adenocarcinoma.
Pavlov K; Honing J; Meijer C; Boersma-van Ek W; Peters FT; van den Berg A; Karrenbeld A; Plukker JT; Kruyt FA; Kleibeuker JH
Dig Liver Dis; 2015 Jan; 47(1):73-80. PubMed ID: 25445407
[TBL] [Abstract][Full Text] [Related]
40. Activation of Akt is increased in the dysplasia-carcinoma sequence in Barrett's oesophagus and contributes to increased proliferation and inhibition of apoptosis: a histopathological and functional study.
Beales IL; Ogunwobi O; Cameron E; El-Amin K; Mutungi G; Wilkinson M
BMC Cancer; 2007 Jun; 7():97. PubMed ID: 17559672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
